BIIB logo

Biogen (BIIB) EBITDA

annual EBITDA:

$2.83B+$791.00M(+38.80%)
December 31, 2024

Summary

  • As of today (June 4, 2025), BIIB annual EBITDA is $2.83 billion, with the most recent change of +$791.00 million (+38.80%) on December 31, 2024.
  • During the last 3 years, BIIB annual EBITDA has fallen by -$50.60 million (-1.76%).
  • BIIB annual EBITDA is now -63.74% below its all-time high of $7.80 billion, reached on December 31, 2019.

Performance

BIIB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

quarterly EBITDA:

$554.40M+$18.90M(+3.53%)
March 31, 2025

Summary

  • As of today (June 4, 2025), BIIB quarterly EBITDA is $554.40 million, with the most recent change of +$18.90 million (+3.53%) on March 31, 2025.
  • Over the past year, BIIB quarterly EBITDA has dropped by -$127.10 million (-18.65%).
  • BIIB quarterly EBITDA is now -74.99% below its all-time high of $2.22 billion, reached on June 30, 2020.

Performance

BIIB quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

TTM EBITDA:

$2.70B-$127.10M(-4.49%)
March 31, 2025

Summary

  • As of today (June 4, 2025), BIIB TTM EBITDA is $2.70 billion, with the most recent change of -$127.10 million (-4.49%) on March 31, 2025.
  • Over the past year, BIIB TTM EBITDA has increased by +$595.50 million (+28.26%).
  • BIIB TTM EBITDA is now -66.54% below its all-time high of $8.08 billion, reached on June 30, 2020.

Performance

BIIB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BIIB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+38.8%-18.6%+28.3%
3 y3 years-1.8%-0.4%-6.7%
5 y5 years-63.7%-70.3%-65.3%

BIIB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.1%+38.8%-64.3%+1064.7%-39.5%+32.6%
5 y5-year-63.7%+38.8%-75.0%+1064.7%-66.5%+32.6%
alltimeall time-63.7%+451.9%-75.0%+154.6%-66.5%+419.8%

BIIB EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$554.40M(+3.5%)
$2.70B(-4.5%)
Dec 2024
$2.83B(+38.8%)
$535.50M(-22.8%)
$2.83B(+1.2%)
Sep 2024
-
$693.60M(-24.5%)
$2.80B(+30.0%)
Jun 2024
-
$918.90M(+34.8%)
$2.15B(+2.1%)
Mar 2024
-
$681.50M(+35.4%)
$2.11B(+3.4%)
Dec 2023
$2.04B(-53.2%)
$503.20M(+957.1%)
$2.04B(-13.9%)
Sep 2023
-
$47.60M(-94.6%)
$2.37B(-38.8%)
Jun 2023
-
$874.60M(+42.7%)
$3.87B(-13.3%)
Mar 2023
-
$613.10M(-26.5%)
$4.47B(+1.3%)
Dec 2022
$4.36B(+51.3%)
$833.60M(-46.3%)
$4.41B(+5.4%)
Sep 2022
-
$1.55B(+5.6%)
$4.18B(+34.0%)
Jun 2022
-
$1.47B(+164.1%)
$3.12B(+7.9%)
Mar 2022
-
$556.60M(-8.2%)
$2.90B(-2.6%)
Dec 2021
$2.88B(-49.8%)
$606.00M(+23.5%)
$2.97B(-1.7%)
Sep 2021
-
$490.60M(-60.5%)
$3.03B(-17.4%)
Jun 2021
-
$1.24B(+95.9%)
$3.66B(-21.0%)
Mar 2021
-
$634.30M(-3.6%)
$4.64B(-21.0%)
Dec 2020
$5.73B(-26.5%)
$658.10M(-41.7%)
$5.87B(-16.8%)
Sep 2020
-
$1.13B(-49.1%)
$7.05B(-12.7%)
Jun 2020
-
$2.22B(+18.9%)
$8.08B(+3.8%)
Mar 2020
-
$1.86B(+1.2%)
$7.78B(-2.1%)
Dec 2019
$7.80B(+14.0%)
$1.84B(-14.5%)
$7.95B(+1.6%)
Sep 2019
-
$2.15B(+12.0%)
$7.82B(-0.7%)
Jun 2019
-
$1.92B(-5.2%)
$7.88B(+7.1%)
Mar 2019
-
$2.03B(+18.1%)
$7.36B(+4.5%)
Dec 2018
$6.85B(+6.0%)
$1.72B(-22.2%)
$7.04B(+0.7%)
Sep 2018
-
$2.21B(+57.5%)
$6.99B(+5.4%)
Jun 2018
-
$1.40B(-18.2%)
$6.63B(+0.4%)
Mar 2018
-
$1.71B(+2.5%)
$6.61B(+2.3%)
Dec 2017
$6.46B(+10.0%)
$1.67B(-9.6%)
$6.46B(+10.1%)
Sep 2017
-
$1.85B(+34.1%)
$5.87B(+4.2%)
Jun 2017
-
$1.38B(-11.7%)
$5.63B(-4.5%)
Mar 2017
-
$1.56B(+44.6%)
$5.90B(+0.4%)
Dec 2016
$5.88B(+7.6%)
$1.08B(-33.0%)
$5.88B(-3.8%)
Sep 2016
-
$1.61B(-1.8%)
$6.10B(+1.5%)
Jun 2016
-
$1.64B(+6.8%)
$6.01B(+4.7%)
Mar 2016
-
$1.54B(+17.5%)
$5.74B(+5.1%)
Dec 2015
$5.46B(+17.1%)
$1.31B(-14.1%)
$5.46B(-0.1%)
Sep 2015
-
$1.52B(+11.0%)
$5.47B(+3.9%)
Jun 2015
-
$1.37B(+9.2%)
$5.27B(+4.1%)
Mar 2015
-
$1.26B(-4.4%)
$5.06B(+8.4%)
Dec 2014
$4.66B(+53.2%)
$1.32B(-0.2%)
$4.66B(+12.0%)
Sep 2014
-
$1.32B(+13.2%)
$4.17B(+13.2%)
Jun 2014
-
$1.16B(+34.8%)
$3.68B(+11.4%)
Mar 2014
-
$864.31M(+5.8%)
$3.30B(+8.5%)
Dec 2013
$3.04B(+34.9%)
$817.28M(-2.0%)
$3.04B(+10.0%)
Sep 2013
-
$833.97M(+5.9%)
$2.77B(+7.8%)
Jun 2013
-
$787.83M(+30.2%)
$2.57B(+7.6%)
Mar 2013
-
$605.02M(+11.7%)
$2.39B(+5.7%)
Dec 2012
$2.26B(+7.3%)
$541.49M(-14.5%)
$2.26B(+1.8%)
Sep 2012
-
$633.61M(+4.5%)
$2.22B(+2.7%)
Jun 2012
-
$606.30M(+27.4%)
$2.16B(+5.3%)
Mar 2012
-
$475.86M(-5.1%)
$2.05B(-6.2%)
Dec 2011
$2.10B(+29.7%)
$501.35M(-13.0%)
$2.19B(+2.1%)
Sep 2011
-
$576.03M(+15.7%)
$2.14B(+15.6%)
Jun 2011
-
$497.79M(-18.5%)
$1.85B(+0.2%)
Mar 2011
-
$610.78M(+34.0%)
$1.85B(+13.9%)
Dec 2010
$1.62B(-9.7%)
$455.68M(+59.0%)
$1.62B(-2.1%)
Sep 2010
-
$286.66M(-41.9%)
$1.66B(-10.8%)
Jun 2010
-
$493.34M(+27.8%)
$1.86B(+6.9%)
Mar 2010
-
$386.11M(-21.4%)
$1.74B(-3.2%)
Dec 2009
$1.80B(+7.6%)
$491.14M(+0.7%)
$1.80B(+3.6%)
Sep 2009
-
$487.92M(+30.6%)
$1.73B(+1.8%)
Jun 2009
-
$373.63M(-15.8%)
$1.70B(-2.2%)
Mar 2009
-
$443.85M(+3.6%)
$1.74B(+4.3%)
Dec 2008
$1.67B(+25.4%)
$428.30M(-6.4%)
$1.67B(-0.6%)
Sep 2008
-
$457.81M(+11.1%)
$1.68B(+12.5%)
Jun 2008
-
$412.22M(+10.9%)
$1.49B(+5.7%)
Mar 2008
-
$371.72M(-15.1%)
$1.41B(+5.9%)
Dec 2007
$1.33B(+53.2%)
$437.80M(+61.6%)
$1.33B(+14.5%)
Sep 2007
-
$270.89M(-18.5%)
$1.16B(-3.2%)
Jun 2007
-
$332.39M(+13.6%)
$1.20B(+42.0%)
Mar 2007
-
$292.61M(+8.9%)
$847.03M(-2.6%)
Dec 2006
$868.93M(+30.1%)
$268.69M(-13.2%)
$869.59M(+8.3%)
Sep 2006
-
$309.48M(-1403.1%)
$802.88M(+26.2%)
Jun 2006
-
-$23.75M(-107.5%)
$636.08M(-21.8%)
Mar 2006
-
$315.18M(+56.0%)
$813.86M(+21.8%)
Dec 2005
$668.05M(+27.9%)
$201.98M(+41.6%)
$668.05M(+3.9%)
Sep 2005
-
$142.68M(-7.4%)
$643.21M(-8.4%)
Jun 2005
-
$154.02M(-9.1%)
$702.41M(+6.7%)
Mar 2005
-
$169.37M(-4.4%)
$658.34M(+26.0%)
Dec 2004
$522.43M
$177.14M(-12.3%)
$522.42M(-178.0%)
DateAnnualQuarterlyTTM
Sep 2004
-
$201.88M(+83.6%)
-$669.48M(-15.2%)
Jun 2004
-
$109.95M(+228.6%)
-$789.47M(-6.6%)
Mar 2004
-
$33.46M(-103.3%)
-$845.16M(+5.1%)
Dec 2003
-$804.13M(-412.0%)
-$1.01B(-1339.1%)
-$804.13M(-429.8%)
Sep 2003
-
$81.89M(+50.9%)
$243.84M(+0.8%)
Jun 2003
-
$54.26M(-27.1%)
$241.85M(-10.7%)
Mar 2003
-
$74.48M(+124.3%)
$270.71M(-9.7%)
Dec 2002
$257.75M(-40.1%)
$33.21M(-58.4%)
$299.84M(-25.4%)
Sep 2002
-
$79.91M(-3.9%)
$401.76M(-12.2%)
Jun 2002
-
$83.11M(-19.8%)
$457.63M(-3.6%)
Mar 2002
-
$103.61M(-23.3%)
$474.62M(+1.8%)
Dec 2001
$430.47M(-18.8%)
$135.13M(-0.5%)
$466.36M(-22.8%)
Sep 2001
-
$135.77M(+35.6%)
$604.18M(+12.2%)
Jun 2001
-
$100.11M(+5.0%)
$538.46M(+0.9%)
Mar 2001
-
$95.35M(-65.1%)
$533.53M(+0.6%)
Dec 2000
$530.45M(+52.7%)
$272.95M(+289.7%)
$530.45M(+30.4%)
Sep 2000
-
$70.05M(-26.4%)
$406.85M(-5.0%)
Jun 2000
-
$95.19M(+3.2%)
$428.30M(+2.9%)
Mar 2000
-
$92.27M(-38.2%)
$416.05M(+6.1%)
Dec 1999
$347.35M(+61.4%)
$149.35M(+63.2%)
$392.30M(+11.9%)
Sep 1999
-
$91.50M(+10.3%)
$350.48M(+11.5%)
Jun 1999
-
$82.93M(+21.0%)
$314.28M(+12.9%)
Mar 1999
-
$68.52M(-36.3%)
$278.35M(+10.4%)
Dec 1998
$215.23M(+27.9%)
$107.53M(+94.4%)
$252.03M(+2.5%)
Sep 1998
-
$55.30M(+17.7%)
$245.96M(+10.0%)
Jun 1998
-
$47.00M(+11.4%)
$223.66M(+6.7%)
Mar 1998
-
$42.20M(-58.4%)
$209.56M(+7.1%)
Dec 1997
$168.26M(+200.0%)
$101.46M(+207.5%)
$195.66M(+34.6%)
Sep 1997
-
$33.00M(+0.3%)
$145.39M(-4.9%)
Jun 1997
-
$32.90M(+16.3%)
$152.89M(+37.5%)
Mar 1997
-
$28.30M(-44.7%)
$111.19M(+41.7%)
Dec 1996
$56.09M(+205.5%)
$51.19M(+26.4%)
$78.49M(+30.9%)
Sep 1996
-
$40.50M(-560.2%)
$59.96M(+206.5%)
Jun 1996
-
-$8.80M(+100.0%)
$19.56M(-29.0%)
Mar 1996
-
-$4.40M(-113.5%)
$27.56M(-17.4%)
Dec 1995
$18.36M(+198.6%)
$32.66M(>+9900.0%)
$33.36M(+35.3%)
Sep 1995
-
$100.00K(-112.5%)
$24.65M(+5389.8%)
Jun 1995
-
-$800.00K(-157.1%)
$449.00K(-980.4%)
Mar 1995
-
$1.40M(-94.2%)
-$51.00K(-100.5%)
Dec 1994
$6.15M(-78.3%)
$23.95M(-199.4%)
$9.75M(-151.6%)
Sep 1994
-
-$24.10M(+1753.8%)
-$18.90M(-227.7%)
Jun 1994
-
-$1.30M(-111.6%)
$14.80M(-45.0%)
Mar 1994
-
$11.20M(-338.3%)
$26.90M(0.0%)
Dec 1993
$28.40M(-20.4%)
-$4.70M(-149.0%)
$26.90M(-53.9%)
Sep 1993
-
$9.60M(-11.1%)
$58.40M(-1.0%)
Jun 1993
-
$10.80M(-3.6%)
$59.00M(+25.8%)
Mar 1993
-
$11.20M(-58.2%)
$46.90M(+33.2%)
Dec 1992
$35.70M(+839.5%)
$26.80M(+162.7%)
$35.20M(+319.0%)
Sep 1992
-
$10.20M(-884.6%)
$8.40M(-660.0%)
Jun 1992
-
-$1.30M(+160.0%)
-$1.50M(-225.0%)
Mar 1992
-
-$500.00K(<-9900.0%)
$1.20M(-69.2%)
Dec 1991
$3.80M(-17.4%)
$0.00(-100.0%)
$3.90M(-39.1%)
Sep 1991
-
$300.00K(-78.6%)
$6.40M(-5.9%)
Jun 1991
-
$1.40M(-36.4%)
$6.80M(+23.6%)
Mar 1991
-
$2.20M(-12.0%)
$5.50M(+25.0%)
Dec 1990
$4.60M(-180.7%)
$2.50M(+257.1%)
$4.40M(-1566.7%)
Sep 1990
-
$700.00K(+600.0%)
-$300.00K(-90.3%)
Jun 1990
-
$100.00K(-90.9%)
-$3.10M(-183.8%)
Mar 1990
-
$1.10M(-150.0%)
$3.70M(-65.4%)
Dec 1989
-$5.70M(-35.2%)
-$2.20M(+4.8%)
$10.70M(-176.4%)
Sep 1989
-
-$2.10M(-130.4%)
-$14.00M(+68.7%)
Jun 1989
-
$6.90M(-14.8%)
-$8.30M(-11.7%)
Mar 1989
-
$8.10M(-130.1%)
-$9.40M(-21.0%)
Dec 1988
-$8.80M(-56.9%)
-$26.90M(-847.2%)
-$11.90M(-25.6%)
Sep 1988
-
$3.60M(-37.9%)
-$16.00M(-10.1%)
Jun 1988
-
$5.80M(+3.6%)
-$17.80M(-18.7%)
Mar 1988
-
$5.60M(-118.1%)
-$21.90M(-9.9%)
Dec 1987
-$20.40M(-18.4%)
-$31.00M(-1822.2%)
-$24.30M(-13.2%)
Sep 1987
-
$1.80M(+5.9%)
-$28.00M(-3.8%)
Jun 1987
-
$1.70M(-46.9%)
-$29.10M(+1.0%)
Mar 1987
-
$3.20M(-109.2%)
-$28.80M(-1.4%)
Dec 1986
-$25.00M(-12.0%)
-$34.70M(-5057.1%)
-$29.20M(-26.3%)
Sep 1986
-
$700.00K(-65.0%)
-$39.60M(+9.1%)
Jun 1986
-
$2.00M(-28.6%)
-$36.30M(+9.3%)
Mar 1986
-
$2.80M(-106.2%)
-$33.20M(+0.6%)
Dec 1985
-$28.40M(+77.5%)
-$45.10M(-1227.5%)
-$33.00M(+38.1%)
Sep 1985
-
$4.00M(-21.6%)
-$23.90M(+8.6%)
Jun 1985
-
$5.10M(+70.0%)
-$22.00M(+2.8%)
Mar 1985
-
$3.00M(-108.3%)
-$21.40M(+5.9%)
Dec 1984
-$16.00M
-$36.00M(-710.2%)
-$20.20M(-227.8%)
Sep 1984
-
$5.90M(+3.5%)
$15.80M(+59.6%)
Jun 1984
-
$5.70M(+35.7%)
$9.90M(+135.7%)
Mar 1984
-
$4.20M
$4.20M

FAQ

  • What is Biogen annual EBITDA?
  • What is the all time high annual EBITDA for Biogen?
  • What is Biogen annual EBITDA year-on-year change?
  • What is Biogen quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Biogen?
  • What is Biogen quarterly EBITDA year-on-year change?
  • What is Biogen TTM EBITDA?
  • What is the all time high TTM EBITDA for Biogen?
  • What is Biogen TTM EBITDA year-on-year change?

What is Biogen annual EBITDA?

The current annual EBITDA of BIIB is $2.83B

What is the all time high annual EBITDA for Biogen?

Biogen all-time high annual EBITDA is $7.80B

What is Biogen annual EBITDA year-on-year change?

Over the past year, BIIB annual EBITDA has changed by +$791.00M (+38.80%)

What is Biogen quarterly EBITDA?

The current quarterly EBITDA of BIIB is $554.40M

What is the all time high quarterly EBITDA for Biogen?

Biogen all-time high quarterly EBITDA is $2.22B

What is Biogen quarterly EBITDA year-on-year change?

Over the past year, BIIB quarterly EBITDA has changed by -$127.10M (-18.65%)

What is Biogen TTM EBITDA?

The current TTM EBITDA of BIIB is $2.70B

What is the all time high TTM EBITDA for Biogen?

Biogen all-time high TTM EBITDA is $8.08B

What is Biogen TTM EBITDA year-on-year change?

Over the past year, BIIB TTM EBITDA has changed by +$595.50M (+28.26%)
On this page